Since taking office on Monday as the 47th president of the United States of America, Donald Trump is hoping to make good on ...

Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...

Hygromycin is under clinical development by Flightpath BioSciences and currently in Phase I for Lyme Disease. According to GlobalData, Phase I drugs for Lyme Disease have a 75% phase transition ...

Vaccinations are critical for protecting pets from infectious diseases. Common vaccines included in wellness plans cover ...

There's nothing like the peace of hugging your dog after a long day—those affectionate nips and cuddles seem to heal ...

Justin Bieber and his wife Hailey Bieber aren't worried about the fan theories sparking up from the pop star unfollowing the Rhode founder last week ...

The bacteria Legionella can survive in water systems for years and can cause acute and chronic illness: In 2014-15, it was blamed for at least 12 deaths in the Flint water crisis in Michigan, and as ...

Capnocytophaga infections in humans are rare, especially in historically healthy individuals. But when it occurs, the disease ...

An international collaboration has achieved an important breakthrough in understanding the genetic mechanisms that allow bacteria to build resistance to drugs.

Evolution is the basis of biological diversity, driven by mechanisms that allow organisms to adapt and survive. One such mechanism is polyploidy, where organisms carry extra copies of their genomes.

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...